Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.

Natchus MG, Bookland RG, De B, Almstead NG, Pikul S, Janusz MJ, Heitmeyer SA, Hookfin EB, Hsieh LC, Dowty ME, Dietsch CR, Patel VS, Garver SM, Gu F, Pokross ME, Mieling GE, Baker TR, Foltz DJ, Peng SX, Bornes DM, Strojnowski MJ, Taiwo YO

Open source

DOI: 10.1021/jm000246e
Published: 2000 Dec 28
Container: Journal of medicinal chemistry
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1021/jm000246e,
  title = {Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.},
  author = {Natchus MG and Bookland RG and De B and Almstead NG and Pikul S and Janusz MJ and Heitmeyer SA and Hookfin EB and Hsieh LC and Dowty ME and Dietsch CR and Patel VS and Garver SM and Gu F and Pokross ME and Mieling GE and Baker TR and Foltz DJ and Peng SX and Bornes DM and Strojnowski MJ and Taiwo YO},
  year = {2000},
  journal = {Journal of medicinal chemistry},
  doi = {10.1021/jm000246e},
  url = {https://doi.org/10.1021/jm000246e}
}

RIS

TY  - JOUR
TI  - Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.
AU  - Natchus MG
AU  - Bookland RG
AU  - De B
AU  - Almstead NG
AU  - Pikul S
AU  - Janusz MJ
AU  - Heitmeyer SA
AU  - Hookfin EB
AU  - Hsieh LC
AU  - Dowty ME
AU  - Dietsch CR
AU  - Patel VS
AU  - Garver SM
AU  - Gu F
AU  - Pokross ME
AU  - Mieling GE
AU  - Baker TR
AU  - Foltz DJ
AU  - Peng SX
AU  - Bornes DM
AU  - Strojnowski MJ
AU  - Taiwo YO
PY  - 2000
JO  - Journal of medicinal chemistry
DO  - 10.1021/jm000246e
UR  - https://doi.org/10.1021/jm000246e
ER  -

APA

MG, N., RG, B., B, D., NG, A., S, P., MJ, J., SA, H., EB, H., LC, H., ME, D., CR, D., VS, P., SM, G., F, G., ME, P., GE, M., TR, B., DJ, F., SX, P., DM, B., MJ, S., & YO, T. (2000). Development of new hydroxamate matrix metalloproteinase inhibitors derived from functionalized 4-aminoprolines.. Journal of medicinal chemistry. https://doi.org/10.1021/jm000246e

Source records

pubmed · retrieved 2026-09-25T08:59:48.913Z